77 results
Page 3 of 4
S-8
EX-99.2
fgqgsnv 6nv37so6oxty
30 Jul 20
Registration of securities for employees
8:39am
6-K
EX-99.1
8juhgbog520wq0bf9
30 Jul 20
Current report (foreign)
7:36am
424B5
bz77lvwm0h4twkfqpjj
20 Jul 20
Prospectus supplement for primary offering
9:21am
6-K
EX-99.1
cvmxi2
20 Jul 20
from 6-K
9:02am
F-3
mt3bdx1f21k708p w010
8 Jul 20
Shelf registration (foreign)
12:00am
6-K
EX-99.1
lkmtf9
30 Jun 20
Current report (foreign)
6:38am
6-K
EX-99.2
vngs08rrf
30 Jun 20
Current report (foreign)
6:38am
6-K
EX-99.1
79w7j75o751
21 May 20
Current report (foreign)
8:09am
6-K
EX-99.1
7ojj4ymcn12v8u
9 Apr 20
Controlling inflammation LIFESCI CAPITAL ALPHA SERIES CONFERENCE 2020
7:26am
6-K
EX-99.3
nh46pjio6l0ii
26 Feb 20
InflaRx Announces Positive Initial Data from Ongoing Phase IIa Open Label Study with IFX-1 in Patients Suffering from Pyoderma Gangraenosum
7:15am
6-K
EX-99.2
q5dkpn
26 Feb 20
InflaRx Announces Positive Initial Data from Ongoing Phase IIa Open Label Study with IFX-1 in Patients Suffering from Pyoderma Gangraenosum
7:15am
6-K
EX-99.1
95fl4mkjlzno sb
16 Jan 20
CONTROLLING INFLAMMATION JP Morgan Corporate Presentation January 2020
4:11pm
6-K
EX-99.1
bd3oo0b4uom209x
14 Nov 19
Current report (foreign)
4:10pm
6-K
EX-99.3
8d0p8phq
7 Nov 19
Current report (foreign)
7:00am
6-K
EX-99.1
ehclrc0885xflokd87
7 Nov 19
Current report (foreign)
7:00am
6-K
EX-99.4
dwisrbve14420by1qn
7 Nov 19
Current report (foreign)
7:00am
6-K
EX-99.1
kg9jv
14 Aug 19
Current report (foreign)
4:16pm
6-K
EX-99.3
auzak e419t
23 May 19
Current report (foreign)
8:00am